Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Asset Writedowns and Impairment: 2011-2014

  • Avadel Pharmaceuticals' Asset Writedowns and Impairment was N/A to $4.3 million in Q2 2014 from the same period last year, while for Jun 2014 it was $32.1 million, marking a year-over-year change of. This contributed to the annual value of $66.1 million for FY2018, which is N/A change from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Asset Writedowns and Impairment stood at $4.3 million for Q2 2014, which was down 6.07% from $4.6 million recorded in Q1 2014.
  • Avadel Pharmaceuticals' 5-year Asset Writedowns and Impairment high stood at $30.3 million for Q4 2011, and its period low was -$7.2 million during Q4 2012.
  • In the last 2 years, Avadel Pharmaceuticals' Asset Writedowns and Impairment had a median value of $4.3 million in 2014 and averaged $581,667.
  • Data for Avadel Pharmaceuticals' Asset Writedowns and Impairment shows a maximum YoY slumped of 123.64% (in 2012) over the last 5 years.
  • Over the past 3 years, Avadel Pharmaceuticals' Asset Writedowns and Impairment (Quarterly) stood at $30.3 million in 2011, then slumped by 123.64% to -$7.2 million in 2012, then reached $4.3 million in 2014.
  • Its Asset Writedowns and Impairment was $4.3 million in Q2 2014, compared to $4.6 million in Q1 2014 and -$7.2 million in Q4 2012.